Gastroenterology & Endoscopy News It is my practice to re-evaluate patients one year after they start an immunomodulator and/or an anti-TNF. At that point, I'll repeat a colonoscopy to ensure that there is mucosal healing. Generally, I do not de-escalate treatment; however, there are ...
Healio “Those on TNF-a inhibitors, both on monotherapy and on dual therapy with an immunomodulator , are at an increased risk of developing malignant solid cancers, relative to those on 5-ASA,” Derrick J. Stobaugh, BA, BS, research study coordinator at ...
Trefis The company is founded on a novel technology—prostone-based compounds, which are essentially derivatives of natural fatty acids. It is the only company we know of that is working in this area. The key product so far is Amitiza (lubiprostone), which ...
Healio “Those on TNF-a inhibitors, both on monotherapy and on dual therapy with an immunomodulator , are at an increased risk of developing malignant solid cancers, relative to those on 5-ASA,” Derrick J. Stobaugh, BA, BS, research study coordinator at ...
Wall Street Sector Selector Is the Parkinson's disease product, the selective adenosine 2a receptor (A2A) antagonist tozadenant (SYN115), driving any value here? CG: Yes. Because Selincro is licensed to Lundbeck, the key operational focus of Biotie is tozadenant, which is, as you ...
EON: Enhanced Online News (press release) AUBAGIO is an immunomodulator with anti-inflammatory properties. Although the exact mechanism of action for AUBAGIO is not fully understood, it may involve a reduction in the number of activated lymphocytes in the central nervous system (CNS).
